Bo Jiang is a Cardiology physician. OpenAlex indexes 36 publications with 454 citations (h-index 9); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2460 Curtis Ellis Dr Bldg 100
Rocky Mount, NC 278042237
Telephone
252-962-2328Provider last certified this registry record 20 Mar 2023.
Clinical trials
- Study of CM383 in Healthy Subjects
Sponsor: Keymed Biosciences Co.Ltd
- TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
Sponsor: Shenzhen TargetRx Co., Ltd.
- The Clinical Application of MCCES in Examination of Human Colon
Sponsor: Nanfang Hospital, Southern Medical University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year202515 payments
- Merck Sharp & Dohme LLCProgram year20257 payments
- PFIZER INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.7%Beta blocker18.6%Metoprolol Succinate58%Carvedilol30%Metoprolol Tartrate11%Atenolol2%Part D<11 patientsCalcium channel blocker10.6%Amlodipine Besylate86%Diltiazem 24hr Er (Cd)11%Cartia Xt3%Part D<11 patients+ 16 more classes in this area
Blood & clotting
14.6%Factor Xa inhibitor12.8%Eliquis69%Xarelto31%Part D≥92 patientsP2Y12 inhibitor1.2%Clopidogrel100%Part D≥21 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.7%SGLT2 inhibitor2.3%Jardiance83%Farxiga17%Part D<11 patientsPotassium supplement0.7%Potassium Chloride62%Klor-Con M2038%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune Cell Crisis and Excess Histopathological Features During the Development and Progression of H. pylori Infection in the Gastric Mucosa
International Journal of General Medicine
2025 - Dosimetric comparison of multiple SBRT delivery platforms for pancreatic cancer
European journal of medical research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”